These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29644923)

  • 41. GLRB allelic variation associated with agoraphobic cognitions, increased startle response and fear network activation: a potential neurogenetic pathway to panic disorder.
    Deckert J; Weber H; Villmann C; Lonsdorf TB; Richter J; Andreatta M; Arias-Vasquez A; Hommers L; Kent L; Schartner C; Cichon S; Wolf C; Schaefer N; von Collenberg CR; Wachter B; Blum R; Schümann D; Scharfenort R; Schumacher J; Forstner AJ; Baumann C; Schiele MA; Notzon S; Zwanzger P; Janzing JGE; Galesloot T; Kiemeney LA; Gajewska A; Glotzbach-Schoon E; Mühlberger A; Alpers G; Fydrich T; Fehm L; Gerlach AL; Kircher T; Lang T; Ströhle A; Arolt V; Wittchen HU; Kalisch R; Büchel C; Hamm A; Nöthen MM; Romanos M; Domschke K; Pauli P; Reif A
    Mol Psychiatry; 2017 Oct; 22(10):1431-1439. PubMed ID: 28167838
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized trial of cognitive-behavioral therapy or selective serotonin reuptake inhibitor or both combined for panic disorder with or without agoraphobia: treatment results through 1-year follow-up.
    van Apeldoorn FJ; Timmerman ME; Mersch PP; van Hout WJ; Visser S; van Dyck R; den Boer JA
    J Clin Psychiatry; 2010 May; 71(5):574-86. PubMed ID: 20492852
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential drug response of panic and agoraphobic avoidance in a case of panic disorder.
    Klein E; Metz L
    Acta Psychiatr Scand; 1990 Jul; 82(1):86-7. PubMed ID: 2399827
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prodromal symptoms in panic disorder with agoraphobia.
    Fava GA; Grandi S; Canestrari R
    Am J Psychiatry; 1988 Dec; 145(12):1564-7. PubMed ID: 3195676
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is a combined therapy more effective than either CBT or SSRI alone? Results of a multicenter trial on panic disorder with or without agoraphobia.
    van Apeldoorn FJ; van Hout WJ; Mersch PP; Huisman M; Slaap BR; Hale WW; Visser S; van Dyck R; den Boer JA
    Acta Psychiatr Scand; 2008 Apr; 117(4):260-70. PubMed ID: 18307586
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A new paradigm (Westphal-Paradigm) to study the neural correlates of panic disorder with agoraphobia.
    Wittmann A; Schlagenhauf F; John T; Guhn A; Rehbein H; Siegmund A; Stoy M; Held D; Schulz I; Fehm L; Fydrich T; Heinz A; Bruhn H; Ströhle A
    Eur Arch Psychiatry Clin Neurosci; 2011 Apr; 261(3):185-94. PubMed ID: 21113608
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disorder-specific emotional imagery for differential and quantitative assessment of agoraphobia.
    Engel KR; Bandelow B; Neumann C; Obst K; Wedekind D
    Curr Pharm Des; 2012; 18(35):5638-44. PubMed ID: 22632470
    [TBL] [Abstract][Full Text] [Related]  

  • 49. (Don't) panic in the scanner! How panic patients with agoraphobia experience a functional magnetic resonance imaging session.
    Lueken U; Muehlhan M; Wittchen HU; Kellermann T; Reinhardt I; Konrad C; Lang T; Wittmann A; Ströhle A; Gerlach AL; Ewert A; Kircher T
    Eur Neuropsychopharmacol; 2011 Jul; 21(7):516-25. PubMed ID: 21269812
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Avoidance behaviour: a predictor of the efficacy of pharmacotherapy in panic disorder?
    Maier W; Roth SM; Argyle N; Buller R; Lavori P; Brandon S; Benkert O
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(3):151-8. PubMed ID: 1790160
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Three year naturalistic outcome study of panic disorder patients treated with paroxetine.
    Dannon PN; Iancu I; Cohen A; Lowengrub K; Grunhaus L; Kotler M
    BMC Psychiatry; 2004 Jun; 4():16. PubMed ID: 15191617
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of NPSR1 gene variation and neural activity in patients with panic disorder and agoraphobia and healthy controls.
    Gechter J; Liebscher C; Geiger MJ; Wittmann A; Schlagenhauf F; Lueken U; Wittchen HU; Pfleiderer B; Arolt V; Kircher T; Straube B; Deckert J; Weber H; Herrmann MJ; Reif A; Domschke K; Ströhle A
    Neuroimage Clin; 2019; 24():102029. PubMed ID: 31734525
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
    Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
    Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Timing matters: change depends on the stage of treatment in cognitive behavioral therapy for panic disorder with agoraphobia.
    Gloster AT; Klotsche J; Gerlach AL; Hamm A; Ströhle A; Gauggel S; Kircher T; Alpers GW; Deckert J; Wittchen HU
    J Consult Clin Psychol; 2014 Feb; 82(1):141-53. PubMed ID: 24188509
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sequential combination of imipramine and self-directed exposure in the treatment of panic disorder with agoraphobia.
    Mavissakalian M
    J Clin Psychiatry; 1990 May; 51(5):184-8. PubMed ID: 2335493
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antipanic drug modulation of 35% CO2 hyperreactivity and short-term treatment outcome.
    Perna G; Bertani A; Caldirola D; Gabriele A; Cocchi S; Bellodi L
    J Clin Psychopharmacol; 2002 Jun; 22(3):300-8. PubMed ID: 12006901
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine.
    Bell C; Forshall S; Adrover M; Nash J; Hood S; Argyropoulos S; Rich A; Nutt DJ
    J Psychopharmacol; 2002 Mar; 16(1):5-14. PubMed ID: 11949771
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Imipramine dose-response relationship in panic disorder with agoraphobia. Preliminary findings.
    Mavissakalian MR; Perel JM
    Arch Gen Psychiatry; 1989 Feb; 46(2):127-31. PubMed ID: 2643933
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional MRI activation in response to panic-specific, non-panic aversive, and neutral pictures in patients with panic disorder and healthy controls.
    Engel KR; Obst K; Bandelow B; Dechent P; Gruber O; Zerr I; Ulrich K; Wedekind D
    Eur Arch Psychiatry Clin Neurosci; 2016 Sep; 266(6):557-66. PubMed ID: 26585457
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diazepam and propranolol in panic disorder and agoraphobia.
    Noyes R; Anderson DJ; Clancy J; Crowe RR; Slymen DJ; Ghoneim MM; Hinrichs JV
    Arch Gen Psychiatry; 1984 Mar; 41(3):287-92. PubMed ID: 6367691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.